Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets

Journal of Psychiatry and Neuroscience

Volumn 32, Issue 1, 2007, Pages 17-22

  Akimoto, Tatsuyuki ^a,b   Kusumi, Ichiro ^a   Suzuki, Katsuji ^a   Masui, Takuya ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kushiro City General Hospital   (Japan)

Author keywords

Calcium; Calmodulin; Platelet; Protein kinase c; Serotonin; Valproate

Indexed keywords

BISINDOLYLMALEIMIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SEROTONIN; STAUROSPORINE; VALPROIC ACID;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; THROMBOCYTE;

EID: 33847048658     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Manji HK, Potter WZ, Lenox RH. Signal transduction pathways; molecular targets for lithium's actions. Arch Gen Psychiatry 1995;52:531-43.
2. Manji HK, Bebchuk JM, Moore GJ, et al. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. J Clin Psychiatry 1999;60(Suppl 2):27-39.
3. 2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry 1991;30:310-2.
4. Kusumi I, Koyama T, Yamashita I. Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology (Berl) 1994;113:322-7.
5. Okamoto Y, Kagaya A, Shinno H. Serotonin-induced platelet calcium mobilization is enhanced in mania. Life Sci 1995;56:327-32.
6. Yamawaki S, Kagaya A, Okamoto Y, et al. Enhanced calcium response to serotonin in platelets from patients with affective disorders. J Psychiatry Neurosci 1996;21:321-4.
7. Suzuki K, Kusumi I, Sasaki Y, et al. Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders: Is it specific to bipolar disorder? J Affect Disord 2001;64:291-6.
8. Keck PE Jr, McElroy SL, Bennett JA. Health-economic implications of the onset of action of antimanic agents. J Clin Psychiatry 1996;57(Suppl 13):13-8.
9. Löscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol 1999;58:31-59.
10. Friedman E, Wang HY, Levinson D, et al. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993;33:520-5.
11. Wang HY, Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 1996;40:568-75.
12. Wang HY, Markowitz P, Levinson D, et al. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatr Res 1999;33:171-9.
13. Chen G, Manji HK, Hawver DB, et al. Chronic sodium valproate selectively decreases protein kinase C∂ and ε in vitro. J Neurochem 1994;63:2361-4.
14. Manji HK, Lenox RH. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999;46:1328-51.
15. Suzuki K, Kusumi I, Akimoto T, et al. Altered 5-HT-induced calcium response in the presence of staurosporine in blood platelets from bipolar disorder patients. Neuropsychopharmacology 2003;28:1210-4.
16. Kusumi I, Suzuki K, Sasaki Y, et al. Treatment response in depressed patients with enhanced calcium mobilization stimulated by serotonin. Neuropsychopharmacology 2000;23:690-6.
17. Suzuki K, Kusumi I, Akimoto T, et al. Effects of lithium and valproate on agonist-induced platelet intracellular calcium mobilization: relevance to myosin light chain kinase. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:67-72.
18. Pletscher A. Platelets as models: use and limitations. Experientia 1988;44:152-5.
19. 2+ response in human platelets. Life Sci 1991;48:2405-12.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
21. Bowden CL, Janicak PG, Orsulak P, et al. Relation of serum valproate concentration to response to mania. Am J Psychiatry 1996;153:765-70.
22. Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology (Berl) 2000;150:15-23.
23. Hidaka H, Sakai Y, Tanaka T, et al. N-(6-aminohexyl)-5-chloro-1- naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A 1981;78:4354-7.
24. 2+ mobilization in rabbit platelets. Eur J Pharmacol 1996;298:175-83.
25. Kis B, Szupera Z, Mezei Z, et al. Valproate treatment and platelet function: the role of arachidonate metabolites. Epilepsia 1999;40:307-10.
26. Bosetti F, Weerasinghe GR, Rosenberger TA, et al. Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J Neurochem 2003;85:690-6.
27. 2+ mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Commun 1986;134:868-75.
28. Roevens P, de Chaffoy de Courcelles D. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction. Biochem J 1995;307:775-82.
29. Watson SP, McNally J, Shipman LJ, et al. The action of protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol triphosphate by thrombin. Biochem J 1988;249:345-50.